Cognition Therapeutics (CGTX) Total Liabilities (2020 - 2026)
Cognition Therapeutics (CGTX) posted quarterly Total Liabilities of $6.2 million for Q1 2026, down 44.53% year-over-year from $11.2 million in Q1 2025, and down 55.88% quarter-over-quarter from $14.1 million in Q4 2025.
Cognition Therapeutics (CGTX) Total Liabilities (2020 - 2026) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Total Liabilities for 7 consecutive years, with $6.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities fell 44.53% year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at $6.2 million (down 44.53% YoY), while the FY2025 annual figure was $14.1 million, up 22.94% from the prior year.
- Total Liabilities fell to $6.2 million in Q1 2026 per CGTX's latest filing, from $14.1 million in the prior quarter.
- Across five years, Total Liabilities topped out at $14.2 million in Q3 2022 and bottomed at $6.2 million in Q1 2026.
- Historically, Total Liabilities has averaged $10.6 million across 5 years, with a median of $10.2 million in 2022.
- Annual changes were most pronounced in 2024 — Total Liabilities jumped 33.02% — and 2025, when it sank 47.58%.
- Cognition Therapeutics' Total Liabilities stood at $10.2 million in 2022, then grew by 5.04% to $10.7 million in 2023, then grew by 7.44% to $11.5 million in 2024, then increased by 22.94% to $14.1 million in 2025, then plunged by 55.88% to $6.2 million in 2026.
- Business Quant data shows CGTX's Total Liabilities at $6.2 million in Q1 2026, $14.1 million in Q4 2025, and $6.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | Cognition Therapeutics | 90.18 Mn | 90.18 Mn | - | 5.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.87 Mn |
| Mar 31, 2026 | 6.23 Mn |
| Dec 31, 2025 | 14.12 Mn |
| Sep 30, 2025 | 6.87 Mn |
| Jun 30, 2025 | 12.59 Mn |
| Mar 31, 2025 | 11.23 Mn |
| Dec 31, 2024 | 11.48 Mn |
| Sep 30, 2024 | 13.10 Mn |
| Jun 30, 2024 | 11.36 Mn |
| Mar 31, 2024 | 9.99 Mn |
| Dec 31, 2023 | 10.69 Mn |
| Sep 30, 2023 | 9.85 Mn |
| Jun 30, 2023 | 9.57 Mn |
| Mar 31, 2023 | 9.88 Mn |
| Dec 31, 2022 | 10.18 Mn |
| Sep 30, 2022 | 14.24 Mn |
| Jun 30, 2022 | 8.91 Mn |
| Mar 31, 2022 | 9.96 Mn |
| Dec 31, 2021 | 7.86 Mn |
| Sep 30, 2021 | 15.35 Mn |